Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,288 public trials 1,201 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer

NCT00064350

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Stanford Comprehensive Cancer Center - Stanford Stanford, California, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 141 locations
View Trial Details
Completed

Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

NCT01824901

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Eastern Cooperative Oncology Group (ECOG) Research Base Brookline, Massachusetts, United States
View Trial Details
Completed

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

NCT00103207

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
  • St. Anthony Central Hospital Denver, Colorado, United States
  • Porter Adventist Hospital Denver, Colorado, United States
View all 157 locations
View Trial Details
Completed

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer

NCT01454934

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Los Angeles, California, United States
  • Pleasant Hill, California, United States
  • San Diego, California, United States
  • Aurora, Colorado, United States
View all 83 locations
View Trial Details
Completed

Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer

NCT01104155

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Bessemer, Alabama, United States
  • Birmingham, Alabama, United States
  • Beverly Hills, California, United States
  • La Jolla, California, United States
View all 64 locations
View Trial Details
Completed

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

NCT02797977

Conditions
Advanced Solid Tumors, Anemia, Anemia, Aplastic, +25 more
Locations
  • Hospital Universitario Vall d'Hebron Barcelona, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • START Madrid Madrid, Spain
  • Hospital Universitario 12 de Octobre Madrid, Spain
View all 20 locations
View Trial Details
Completed

Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer

NCT01126736

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Tucson, Arizona, United States
  • Denver, Colorado, United States
  • Fort Myers, Florida, United States
  • Mount Holly, New Jersey, United States
View all 18 locations
View Trial Details
Completed

Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer

NCT00002667

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
  • CCOP - Northern New Jersey Hackensack, New Jersey, United States
  • Ireland Cancer Center Cleveland, Ohio, United States
View Trial Details

Related conditions